Supplementary Table S1 from Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
收藏NIAID Data Ecosystem2026-05-16 收录
数据链接：
官方服务：
资源简介：
Supplementary Table S1 from Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
创建时间：
2011-05-15
